GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Left main coronary artery (LMCA) disease can lead to what's known as a "widowmaker" heart attack, so-called because of the ...

Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

Mesoblast shares lifted in morning trade after the biotech said it had aligned with the US Food and Drug Administration (FDA) ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...

Heart attack survival odds have dramatically improved over the past 5 decades, but more people are dying from chronic cardiac ...